Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Healthcare Services Industry Analysis

UpdatedFeb 23, 2026
DataAggregated Company Financials
Companies11
  • 7D1.2%
  • 3M1.3%
  • 1Y11.9%
  • YTD9.2%

The Healthcare Services is pretty flat in the last 7 days, but Integrated Diagnostics Holdings has stood out, gaining 8.9%. As for the the longer term, the industry is up 12% over the past 12 months. Looking forward, earnings are forecast to grow by 22% annually.

Industry Valuation and Performance

Has the U.K. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 23 Feb 2026UK£2.4bUK£2.4bUK£56.8m29.5x41.5x1x
Wed, 21 Jan 2026UK£2.2bUK£2.4bUK£56.8m26.2x38.6x0.9x
Fri, 19 Dec 2025UK£2.1bUK£2.4bUK£52.1m26.9x41.1x0.9x
Sun, 16 Nov 2025UK£2.3bUK£2.4bUK£52.3m30x44x0.9x
Tue, 14 Oct 2025UK£2.5bUK£2.4bUK£52.1m35.1x47.4x1x
Thu, 11 Sep 2025UK£5.0bUK£5.0bUK£141.9m31.5x35.6x1x
Sat, 09 Aug 2025UK£4.9bUK£5.0bUK£140.8m31.5x35.1x1x
Mon, 07 Jul 2025UK£2.2bUK£2.5bUK£57.2m13.4x38x0.9x
Wed, 04 Jun 2025UK£2.1bUK£2.5bUK£55.4m14.8x37.7x0.8x
Fri, 02 May 2025UK£2.0bUK£2.5bUK£55.4m14.8x36.2x0.8x
Sun, 30 Mar 2025UK£1.8bUK£2.4bUK£46.4m14.8x39.5x0.8x
Tue, 25 Feb 2025UK£2.0bUK£2.3bUK£55.7m17x36.6x0.9x
Thu, 23 Jan 2025UK£2.1bUK£2.3bUK£55.5m19.7x37.1x0.9x
Sat, 21 Dec 2024UK£1.9bUK£2.3bUK£55.6m18.8x34.6x0.8x
Mon, 18 Nov 2024UK£1.9bUK£2.3bUK£56.3m13.8x33.2x0.8x
Wed, 16 Oct 2024UK£2.1bUK£2.4bUK£55.1m24.2x37.6x0.9x
Fri, 13 Sep 2024UK£2.3bUK£2.2bUK£58.1m18.1x38.8x1x
Sun, 11 Aug 2024UK£2.2bUK£2.2bUK£56.3m17.5x39.3x1x
Tue, 09 Jul 2024UK£2.1bUK£2.3bUK£65.6m16.2x32.3x0.9x
Thu, 06 Jun 2024UK£2.3bUK£2.3bUK£65.1m17.7x34.8x1x
Sat, 04 May 2024UK£2.1bUK£2.2bUK£60.1m18.8x35x0.9x
Mon, 01 Apr 2024UK£2.1bUK£2.2bUK£59.3m20.9x35.1x0.9x
Wed, 28 Feb 2024UK£2.6bUK£2.2bUK£66.0m19.9x39x1.2x
Fri, 26 Jan 2024UK£7.7bUK£6.5bUK£312.7m21.9x24.6x1.2x
Sun, 24 Dec 2023UK£7.7bUK£6.5bUK£312.7m21.9x24.6x1.2x
Tue, 21 Nov 2023UK£7.6bUK£6.5bUK£315.3m17.3x24x1.2x
Thu, 19 Oct 2023UK£7.6bUK£6.5bUK£308.8m22.7x24.5x1.2x
Sat, 16 Sep 2023UK£7.6bUK£6.4bUK£283.7m23x26.6x1.2x
Mon, 14 Aug 2023UK£8.1bUK£6.4bUK£286.3m23.8x28.2x1.3x
Wed, 12 Jul 2023UK£7.8bUK£6.4bUK£286.1m21.9x27.4x1.2x
Fri, 09 Jun 2023UK£7.9bUK£6.4bUK£285.0m36.3x27.7x1.2x
Sun, 07 May 2023UK£8.0bUK£6.4bUK£288.8m36.4x27.7x1.3x
Tue, 04 Apr 2023UK£7.6bUK£6.4bUK£295.4m26.8x25.9x1.2x
Thu, 02 Mar 2023UK£7.8bUK£6.4bUK£295.5m27x26.4x1.2x
Price to Earnings Ratio

26.4x


Total Market Cap: UK£7.8bTotal Earnings: UK£295.5mTotal Revenue: UK£6.4bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Healthcare Services Industry Price to Earnings3Y Average 34.1x202420252026
Current Industry PE
  • Investors are optimistic on the British Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 41.5x which is higher than its 3-year average PE of 34.1x.
  • The industry is trading close to its 3-year average PS ratio of 1.0x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 42% per year over the last three years,
  • Revenues have also declined 27% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.88%
Healthcare0.92%
Healthcare Services1.17%
Healthcare Services4.51%
Healthcare Facilities0.33%
Healthcare Distributors0%0
Industry PE
  • Investors are most optimistic about the Healthcare Facilities industry which is trading above its 3-year average PE ratio of 31.9x.
    • Analysts are expecting annual earnings growth of 22.4%, which is higher than its past year's earnings decline of 28.7% per year.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 219x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Facilities industry, expecting annual earnings growth of 22% over the next 5 years.
  • This is better than its past earnings decline of 29% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EDX EDX Medical GroupUK£0.13-3.8%
UK£3.0m		0%n/a
IDHC Integrated Diagnostics HoldingsUS$0.670.8%
+US$2.9m		78.7%PE14.1x
CVSG CVS GroupUK£13.980.1%
+UK£1.4m		34.4%PE51.9x
OHGR One Health GroupUK£2.352.2%
+UK£691.6k		20.5%n/a
TRLS Trellus HealthUK£0.00727.3%
+UK£318.9k		-62.2%PS5x

Latest News

IDHC
US$0.67
Integrated Diagnostics Holdings
7D
0.8%
1Y
78.7%

IDHC: Fair Value View Will Reflect Slightly Stronger Margins And Earnings Multiple

Analysts have slightly raised their price target on Integrated Diagnostics Holdings to $0.71 from $0.70, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E that together indicate a modestly improved outlook in their models. Valuation Changes Fair Value: Model fair value per share has moved from $0.70 to about $0.71, reflecting a small upward adjustment in the valuation output.
CVSG
UK£13.98
CVS Group
7D
0.1%
1Y
34.4%

CVSG: Completed Buyback And Stable Assumptions Will Shape Balanced Near Term Outlook

Analysts have made only a marginal tweak to their fair value outlook for CVS Group, keeping the target around £14.20, as small adjustments to discount rate, revenue growth, profit margin and future P/E assumptions offset each other rather than driving a clear shift in valuation. What's in the News CVS Group completed a share buyback tranche, repurchasing 1,584,690 shares for £20 million, equal to 2.21% of the company.
EDX
UK£0.13
EDX Medical Group
7D
-3.8%
1Y
0%
PHSC
UK£0.08
PHSC
7D
-23.8%
1Y
-57.9%
TRLS
UK£0.007
Trellus Health
7D
27.3%
1Y
-62.2%
MPAL
UK£0.048
MedPal AI
7D
-9.5%
1Y
n/a
SPI
UK£2.00
Spire Healthcare Group
7D
-2.4%
1Y
-12.5%

SPI: Stable Fair Value And Slight P/E Shift Will Support Upside

Analysts have marginally lifted their price target on Spire Healthcare Group, reflecting small tweaks to the discount rate and long term P/E assumptions rather than any major shift in the underlying £ fair value framework. Valuation Changes Fair Value: £2.65 per share is unchanged, with no revision to the core £ fair value estimate.
OHGR
UK£2.35
One Health Group
7D
2.2%
1Y
20.5%
KOO
UK£1.23
Kooth
7D
-0.8%
1Y
-18.5%
GENI
UK£0.011
GENinCode
7D
-2.3%
1Y
-70.4%